Clarifying the role of EMSY in DNA repair in ovarian cancer
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:125 |
---|---|
Enthalten in: |
Cancer - 125(2019), 16 vom: 15. Aug., Seite 2720-2724 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kondrashova, Olga [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 18.05.2020 Date Revised 18.05.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/cncr.32135 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM297723189 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM297723189 | ||
003 | DE-627 | ||
005 | 20231225092620.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/cncr.32135 |2 doi | |
028 | 5 | 2 | |a pubmed24n0992.xml |
035 | |a (DE-627)NLM297723189 | ||
035 | |a (NLM)31154666 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kondrashova, Olga |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clarifying the role of EMSY in DNA repair in ovarian cancer |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.05.2020 | ||
500 | |a Date Revised 18.05.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a DNA repair | |
650 | 4 | |a EMSY amplification | |
650 | 4 | |a EMSY overexpression | |
650 | 4 | |a PARP inhibitors | |
650 | 4 | |a homologous recombination | |
650 | 4 | |a ovarian cancer | |
650 | 7 | |a EMSY protein, human |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
650 | 7 | |a Nuclear Proteins |2 NLM | |
650 | 7 | |a Repressor Proteins |2 NLM | |
650 | 7 | |a RAD51 protein, human |2 NLM | |
650 | 7 | |a EC 2.7.7.- |2 NLM | |
650 | 7 | |a Rad51 Recombinase |2 NLM | |
650 | 7 | |a EC 2.7.7.- |2 NLM | |
700 | 1 | |a Scott, Clare L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer |d 1948 |g 125(2019), 16 vom: 15. Aug., Seite 2720-2724 |w (DE-627)NLM000028649 |x 1097-0142 |7 nnns |
773 | 1 | 8 | |g volume:125 |g year:2019 |g number:16 |g day:15 |g month:08 |g pages:2720-2724 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/cncr.32135 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 125 |j 2019 |e 16 |b 15 |c 08 |h 2720-2724 |